Banca Mediolanum S.p.A. (BMED.XMIL) Quality Score

Quality64

Business quality is the primary weakness (avg 73/100). Growth is the relative bright spot.

Broad-market heuristics · Not a buy/sell signal

Export

Valuation and growth

Valuation

Growth

Revenue Growth

100/100

20.0%

Above 10% CAGR, strong compounder

Book Value Growth

100/100

15.0%

Above 8% book-value compounding, strong

Business Quality & Capital Allocation

Share Dilution

60/100

0.3%

Mild dilution under 2%

Return on Equity

100/100

27.5%

Above 15%, strong return on equity

Capital Adequacy

30/100

5.0%

5.0% equity/assets, thin

Margin Trend

100/100

+14.8pp

Net margin expanded 3+pp, strong improvement

Related stocks: Banks - Regional

CE.XMILCredito Emiliano S.p.A.FBK.XMILFinecoBank Banca Fineco S.p.A.AZM.XMILAzimut Holding S.p.A.ANIM.XMILAnima Holding S.p.A.BGN.XMILBanca Generali S.p.A.BDB.XMILBanco di Desio e della Brianza S.p.A.DOV.XMILdoValue S.p.A.BFF.XMILBFF Bank S.p.A.

Spot a number that looks wrong? Report a data issue

Data sourced from company filings and third-party price providers. Scores, valuations, and metrics are algorithmic estimates. This is not investment advice. See our Terms and Methodology.